•
Sep 30, 2023

Immix Biopharma Q3 2023 Earnings Report

EPS
-$0.23
Previous year: -$0.11
+109.1%
Gross Profit
-$1.38K
Cash and Equivalents
$19.6M
Previous year: $16.9M
+15.8%
Free Cash Flow
-$3.13M
Total Assets
$22.5M
Previous year: $17.4M
+29.2%

Immix Biopharma

Immix Biopharma